Related references
Note: Only part of the references are listed.Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
Jianhui Ma et al.
CANCER CELL (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+T regulatory cells
Thiago Vidotto et al.
PROSTATE (2019)
Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis
Antonio Raffone et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2019)
Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities
Sherri Z. Millis et al.
CANCER (2019)
Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
Gregor Hutter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer
Jae Won Yun et al.
TRANSLATIONAL ONCOLOGY (2019)
Cytosolic DNA Sensing in Organismal Tumor Control
Claire Vanpouille-Box et al.
CANCER CELL (2018)
Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma
Yubing Wang et al.
CANCER LETTERS (2018)
STING Signaling Promotes Inflammation in Experimental Acute Pancreatitis
Qinglan Zhao et al.
GASTROENTEROLOGY (2018)
The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer
Tuo Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms
Marco Bezzi et al.
NATURE MEDICINE (2018)
The functions and regulation of the PTEN tumour suppressor: new modes and prospects
Yu-Ru Lee et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer
W. Y. Mansour et al.
SCIENTIFIC REPORTS (2018)
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flavia Castro et al.
FRONTIERS IN IMMUNOLOGY (2018)
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
Xiaoxiao Wang et al.
NEOPLASIA (2018)
Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung
Aung Myo Hlaing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Mitochondrial dsRNA: A New DAMP for MDA5
Andreas Linder et al.
DEVELOPMENTAL CELL (2018)
PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
Luke Russell et al.
NATURE COMMUNICATIONS (2018)
Oncolytic virus immunotherapy: future prospects for oncology
Junaid Raja et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers
Michael T. Barrett et al.
BREAST CANCER RESEARCH (2018)
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project
K. M. Kerr et al.
ANNALS OF ONCOLOGY (2018)
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George et al.
IMMUNITY (2017)
Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling
Meng Michelle Xu et al.
IMMUNITY (2017)
Cell Cycle Control by PTEN
Andrew Brandmaier et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas
D. Yan et al.
ONCOGENE (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
Ruan F. V. Medrano et al.
ONCOTARGET (2017)
Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
T. J. Mitchison et al.
OPEN BIOLOGY (2017)
Cancer cell and macrophage cross-talk in the tumor microenvironment
Nathalie Dehnel et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
The functions of tumor suppressor PTEN in innate and adaptive immunity
Lang Chen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site
Takayuki Ohkuri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
The tumor suppressor PTEN has a critical role in antiviral innate immunity
Shun Li et al.
NATURE IMMUNOLOGY (2016)
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng et al.
CANCER DISCOVERY (2016)
Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapy
Leticia Corrales et al.
CYTOKINE (2016)
A PTENtial cause for the selectivity of oncolytic viruses?
Brian R. Champion et al.
NATURE IMMUNOLOGY (2016)
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
Sarah T. Garber et al.
NEURO-ONCOLOGY (2016)
Immunotherapy and Oncogenic Pathways: The PTEN Connection
Naiyer A. Rizvi et al.
CANCER DISCOVERY (2016)
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker et al.
NATURE REVIEWS CANCER (2016)
Loss of PTEN causes SHP2 activation, making lung cancer cells unresponsive to IFN-γ
Chia-Ling Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients
Amir Khammari et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Juan Fu et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
PTEN mediates Notch-dependent stalk cell arrest in angiogenesis
Helena Serra et al.
NATURE COMMUNICATIONS (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas
Hiroshi Kawaji et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
Chunxiao Xu et al.
CANCER CELL (2014)
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola H. Ries et al.
CANCER CELL (2014)
Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAFV600 Mutations
Amanda D. Bucheit et al.
CLINICAL CANCER RESEARCH (2014)
Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma
Mohammad Atefi et al.
CLINICAL CANCER RESEARCH (2014)
Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA
Henrique Lemos et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity
Haifeng C. Xu et al.
IMMUNITY (2014)
Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1
Josh Crouse et al.
IMMUNITY (2014)
PTEN in smooth muscle cells is essential for colonic immune homeostasis
Xin Qi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression
Alejandro J. Garcia et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
PTEN functions as a melanoma tumor suppressor by promoting host immune response
Y. Dong et al.
ONCOGENE (2014)
Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy
Mette Ilander et al.
PLOS ONE (2014)
Interferons and Their Stimulated Genes in the Tumor Microenvironment
HyeonJoo Cheon et al.
SEMINARS IN ONCOLOGY (2014)
Enhancing Chemotherapy Efficacy in Pten-Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity
Alberto Toso et al.
CELL REPORTS (2014)
STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
Takayuki Ohkuri et al.
CANCER IMMUNOLOGY RESEARCH (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Interferon-α Suppresses cAMP to Disarm Human Regulatory T Cells
Nicole Bacher et al.
CANCER RESEARCH (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer
Minmin Song et al.
PLOS ONE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
Kim H. T. Paraiso et al.
CANCER RESEARCH (2011)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
Mycobacterium tuberculosis Triggers Host Type I IFN Signaling To Regulate IL-1β Production in Human Macrophages
Aleksey Novikov et al.
JOURNAL OF IMMUNOLOGY (2011)
PTEN Is a Major Tumor Suppressor in Pancreatic Ductal Adenocarcinoma and Regulates an NF-κB-Cytokine Network
Haoqiang Ying et al.
CANCER DISCOVERY (2011)
Interferon-gamma in Brain Tumor Immunotherapy
Ari Kane et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2010)
Clinical Use of Interferon-gamma
Catriona H. T. Miller et al.
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS (2009)
PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
C. A. Crane et al.
ONCOGENE (2009)
Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity
Paola M. Barral et al.
PHARMACOLOGY & THERAPEUTICS (2009)
IFN-α skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo
Claudia Papewalis et al.
JOURNAL OF IMMUNOLOGY (2008)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Phosphatase and tensin homologue deficiency in giloblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir
Zibin Jiang et al.
CANCER RESEARCH (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-α treatment
B Guillot et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Lack of PTEN sequesters CHK1 and initiates genetic instability
J Puc et al.
CANCER CELL (2005)
Interferons, interferon-like cytokines, and their receptors
S Pestka et al.
IMMUNOLOGICAL REVIEWS (2004)
Links between innate and adaptive immunity via type I interferon
A Le Bon et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases
J Liliental et al.
CURRENT BIOLOGY (2000)
Share Paper
